ARQT
Arcutis Biotherapeutics, Inc.$23.27-0.14 (-0.62%)Prev Close$23.42·MCap$2.89B·P/E—·Vol694.5K·Yield—
▲
Buys (12M)
6
$373.0K
▼
Sells (12M)
57
$16.05M
◆
Net Activity
Net Seller
$15.67M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Arcutis Biotherapeutics, Inc. (ARQT) has been dominated by selling, with 6 insider purchases totaling $373.0K and 57 insider sales totaling $16.05M. The most recent insider transaction was by Welgus Howard G. (director), who sold $238.8K worth of shares on Apr 3, 2026. Arcutis Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.89B.
ARQT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | Welgus Howard G. | director | Sell | 10,000 | $23.88 | $238.8K | 39,744 |
| Feb 4, 2026 | Burnett Patrick | officer: See Remarks | Sell | 13,469 | $25.72 | $346.5K | 90,445 |
| Feb 4, 2026 | Edwards Larry Todd | officer: See Remarks | Sell | 2,052 | $25.50 | $52.3K | 148,865 |
| Feb 4, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 7,983 | $25.50 | $203.6K | 142,658 |
| Feb 4, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 63,607 |
| Feb 4, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 19,833 | $25.50 | $505.7K | 721,306 |
| Feb 4, 2026 | Welgus Howard G. | director | Sell | 10,000 | $25.05 | $250.5K | 59,744 |
| Feb 2, 2026 | Burnett Patrick | See Remarks | Sell | 13,469 | $25.72 | $346.5K | 0 |
| Feb 2, 2026 | Edwards Larry Todd | See Remarks | Sell | 2,052 | $25.50 | $52.3K | 0 |
| Feb 2, 2026 | Matsuda Masaru | See Remarks | Sell | 40,638 | $25.28 | $1.03M | 0 |
| Feb 2, 2026 | Vairavan Latha | SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 0 |
| Feb 2, 2026 | Watanabe Todd | See Remarks | Sell | 19,833 | $25.50 | $505.7K | 0 |
| Feb 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $25.05 | $250.5K | 0 |
| Jan 7, 2026 | Burnett Patrick | officer: See Remarks | Sell | 2,490 | $28.98 | $72.2K | 94,120 |
| Jan 6, 2026 | Welgus Howard G. | director | Sell | 10,000 | $28.96 | $289.6K | 69,744 |
| Jan 5, 2026 | Burnett Patrick | See Remarks | Sell | 2,490 | $28.98 | $72.2K | 0 |
| Jan 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $28.96 | $289.6K | 0 |
| Dec 31, 2025 | Burnett Patrick | See Remarks | Sell | 1,697 | $29.20 | $49.6K | 0 |
| Dec 15, 2025 | Burnett Patrick | See Remarks | Sell | 11,500 | $28.94 | $332.9K | 0 |
| Dec 1, 2025 | Matsuda Masaru | See Remarks | Sell | 1,657 | $30.23 | $50.1K | 0 |
| Dec 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $30.21 | $302.1K | 0 |
| Nov 24, 2025 | LIN SUE-JEAN | Director | Sell | 25,272 | $30.78 | $778.0K | 0 |
| Nov 21, 2025 | Watanabe Todd | See Remarks | Sell | 50,000 | $30.35 | $1.52M | 0 |
| Nov 20, 2025 | Gilbert Halley E | Director | Sell | 16,532 | $27.55 | $455.4K | 0 |
| Nov 19, 2025 | Matsuda Masaru | See Remarks | Sell | 2,550 | $28.29 | $72.1K | 0 |
| Nov 13, 2025 | Krishnamohan Neha | Director | Sell | 40,504 | $23.20 | $939.5K | 0 |
| Nov 6, 2025 | Burnett Patrick | See Remarks | Sell | 17,250 | $24.18 | $417.1K | 0 |
| Nov 6, 2025 | Edwards Larry Todd | See Remarks | Sell | 29,131 | $25.16 | $732.9K | 0 |
| Nov 3, 2025 | Burnett Patrick | See Remarks | Sell | 6,486 | $24.12 | $156.4K | 0 |
| Nov 3, 2025 | Matsuda Masaru | See Remarks | Sell | 7,208 | $24.72 | $178.2K | 0 |
| Nov 3, 2025 | Vairavan Latha | SVP Chief Financial Officer | Sell | 88 | $24.72 | $2.2K | 0 |
| Nov 3, 2025 | Watanabe Todd | See Remarks | Sell | 11,547 | $24.72 | $285.4K | 0 |
| Nov 3, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $25.27 | $252.7K | 0 |
| Oct 28, 2025 | Watanabe Todd | See Remarks | Sell | 40,000 | $25.03 | $1.00M | 0 |
| Oct 2, 2025 | Edwards Larry Todd | See Remarks | Sell | 4,504 | $20.04 | $90.3K | 0 |
| Oct 1, 2025 | Watanabe Todd | See Remarks | Sell | 45,000 | $19.66 | $884.6K | 0 |
| Oct 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $18.92 | $189.2K | 0 |
| Sep 8, 2025 | Watanabe Todd | See Remarks | Sell | 10,129 | $17.54 | $177.6K | 0 |
| Sep 4, 2025 | Matsuda Masaru | See Remarks | Sell | 36,130 | $16.16 | $583.7K | 0 |
| Sep 2, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $15.64 | $156.4K | 0 |
| Aug 19, 2025 | Burnett Patrick | See Remarks | Sell | 4,188 | $15.82 | $66.2K | 0 |
| Aug 8, 2025 | Burnett Patrick | See Remarks | Sell | 3,847 | $14.03 | $54.0K | 0 |
| Aug 4, 2025 | Burnett Patrick | See Remarks | Sell | 2,622 | $14.33 | $37.6K | 0 |
| Aug 4, 2025 | Matsuda Masaru | See Remarks | Sell | 6,330 | $14.33 | $90.7K | 0 |
| Aug 4, 2025 | Vairavan Latha | SVP Chief Financial Officer | Sell | 89 | $14.33 | $1.3K | 0 |
| Aug 4, 2025 | Watanabe Todd | See Remarks | Sell | 11,547 | $14.33 | $165.4K | 0 |
| Aug 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $14.30 | $143.0K | 0 |
| Jul 10, 2025 | Burnett Patrick | See Remarks | Sell | 28,750 | $15.05 | $432.7K | 0 |
| Jul 1, 2025 | Welgus Howard G. | Director | Sell | 9,208 | $13.84 | $127.4K | 0 |
| Jun 18, 2025 | Welgus Howard G. | Director | Sell | 10,139 | $13.37 | $135.6K | 0 |
Showing 1–50 of 210
1 / 5
ARQT Insider Buying Activity
The following table shows recent insider purchases of Arcutis Biotherapeutics, Inc. (ARQT) stock reported via SEC Form 4 filings.
No insider buying activity found for ARQT in the last 12 months.
ARQT Insider Selling Activity
The following table shows recent insider sales of Arcutis Biotherapeutics, Inc. (ARQT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | Welgus Howard G. | director | Sell | 10,000 | $23.88 | $238.8K | 39,744 |
| Feb 4, 2026 | Burnett Patrick | officer: See Remarks | Sell | 13,469 | $25.72 | $346.5K | 90,445 |
| Feb 4, 2026 | Edwards Larry Todd | officer: See Remarks | Sell | 2,052 | $25.50 | $52.3K | 148,865 |
| Feb 4, 2026 | Matsuda Masaru | officer: See Remarks | Sell | 7,983 | $25.50 | $203.6K | 142,658 |
| Feb 4, 2026 | Vairavan Latha | officer: SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 63,607 |
| Feb 4, 2026 | Watanabe Todd | director, officer: See Remarks | Sell | 19,833 | $25.50 | $505.7K | 721,306 |
| Feb 4, 2026 | Welgus Howard G. | director | Sell | 10,000 | $25.05 | $250.5K | 59,744 |
| Feb 2, 2026 | Burnett Patrick | See Remarks | Sell | 13,469 | $25.72 | $346.5K | 0 |
| Feb 2, 2026 | Edwards Larry Todd | See Remarks | Sell | 2,052 | $25.50 | $52.3K | 0 |
| Feb 2, 2026 | Matsuda Masaru | See Remarks | Sell | 40,638 | $25.28 | $1.03M | 0 |
| Feb 2, 2026 | Vairavan Latha | SVP Chief Financial Officer | Sell | 1,320 | $25.50 | $33.7K | 0 |
| Feb 2, 2026 | Watanabe Todd | See Remarks | Sell | 19,833 | $25.50 | $505.7K | 0 |
| Feb 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $25.05 | $250.5K | 0 |
| Jan 7, 2026 | Burnett Patrick | officer: See Remarks | Sell | 2,490 | $28.98 | $72.2K | 94,120 |
| Jan 6, 2026 | Welgus Howard G. | director | Sell | 10,000 | $28.96 | $289.6K | 69,744 |
| Jan 5, 2026 | Burnett Patrick | See Remarks | Sell | 2,490 | $28.98 | $72.2K | 0 |
| Jan 2, 2026 | Welgus Howard G. | Director | Sell | 10,000 | $28.96 | $289.6K | 0 |
| Dec 31, 2025 | Burnett Patrick | See Remarks | Sell | 1,697 | $29.20 | $49.6K | 0 |
| Dec 15, 2025 | Burnett Patrick | See Remarks | Sell | 11,500 | $28.94 | $332.9K | 0 |
| Dec 1, 2025 | Matsuda Masaru | See Remarks | Sell | 1,657 | $30.23 | $50.1K | 0 |
| Dec 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $30.21 | $302.1K | 0 |
| Nov 24, 2025 | LIN SUE-JEAN | Director | Sell | 25,272 | $30.78 | $778.0K | 0 |
| Nov 21, 2025 | Watanabe Todd | See Remarks | Sell | 50,000 | $30.35 | $1.52M | 0 |
| Nov 20, 2025 | Gilbert Halley E | Director | Sell | 16,532 | $27.55 | $455.4K | 0 |
| Nov 19, 2025 | Matsuda Masaru | See Remarks | Sell | 2,550 | $28.29 | $72.1K | 0 |
| Nov 13, 2025 | Krishnamohan Neha | Director | Sell | 40,504 | $23.20 | $939.5K | 0 |
| Nov 6, 2025 | Burnett Patrick | See Remarks | Sell | 17,250 | $24.18 | $417.1K | 0 |
| Nov 6, 2025 | Edwards Larry Todd | See Remarks | Sell | 29,131 | $25.16 | $732.9K | 0 |
| Nov 3, 2025 | Burnett Patrick | See Remarks | Sell | 6,486 | $24.12 | $156.4K | 0 |
| Nov 3, 2025 | Matsuda Masaru | See Remarks | Sell | 7,208 | $24.72 | $178.2K | 0 |
| Nov 3, 2025 | Vairavan Latha | SVP Chief Financial Officer | Sell | 88 | $24.72 | $2.2K | 0 |
| Nov 3, 2025 | Watanabe Todd | See Remarks | Sell | 11,547 | $24.72 | $285.4K | 0 |
| Nov 3, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $25.27 | $252.7K | 0 |
| Oct 28, 2025 | Watanabe Todd | See Remarks | Sell | 40,000 | $25.03 | $1.00M | 0 |
| Oct 2, 2025 | Edwards Larry Todd | See Remarks | Sell | 4,504 | $20.04 | $90.3K | 0 |
| Oct 1, 2025 | Watanabe Todd | See Remarks | Sell | 45,000 | $19.66 | $884.6K | 0 |
| Oct 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $18.92 | $189.2K | 0 |
| Sep 8, 2025 | Watanabe Todd | See Remarks | Sell | 10,129 | $17.54 | $177.6K | 0 |
| Sep 4, 2025 | Matsuda Masaru | See Remarks | Sell | 36,130 | $16.16 | $583.7K | 0 |
| Sep 2, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $15.64 | $156.4K | 0 |
| Aug 19, 2025 | Burnett Patrick | See Remarks | Sell | 4,188 | $15.82 | $66.2K | 0 |
| Aug 8, 2025 | Burnett Patrick | See Remarks | Sell | 3,847 | $14.03 | $54.0K | 0 |
| Aug 4, 2025 | Burnett Patrick | See Remarks | Sell | 2,622 | $14.33 | $37.6K | 0 |
| Aug 4, 2025 | Matsuda Masaru | See Remarks | Sell | 6,330 | $14.33 | $90.7K | 0 |
| Aug 4, 2025 | Vairavan Latha | SVP Chief Financial Officer | Sell | 89 | $14.33 | $1.3K | 0 |
| Aug 4, 2025 | Watanabe Todd | See Remarks | Sell | 11,547 | $14.33 | $165.4K | 0 |
| Aug 1, 2025 | Welgus Howard G. | Director | Sell | 10,000 | $14.30 | $143.0K | 0 |
| Jul 10, 2025 | Burnett Patrick | See Remarks | Sell | 28,750 | $15.05 | $432.7K | 0 |
| Jul 1, 2025 | Welgus Howard G. | Director | Sell | 9,208 | $13.84 | $127.4K | 0 |
| Jun 18, 2025 | Welgus Howard G. | Director | Sell | 10,139 | $13.37 | $135.6K | 0 |
ARQT Insiders
Similar Stocks to ARQT
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B